Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ: CABA )

1.780 -0.130 (-6.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/24
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Via Benzinga
7 Analysts Have This to Say About Cabaletta Bio
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/23
Via Investor Brand Network
The Latest Analyst Ratings for Cabaletta Bio
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
Via Benzinga
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 9/12
Via Investor Brand Network
Analyst Ratings for Cabaletta Bio
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/23
Via Investor Brand Network
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/18
Via Investor Brand Network
HC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
Via Benzinga
Why Shares of Cabaletta Bio Are Up Tuesday
The biotech stock rose after an analyst upgrade. 
Via The Motley Fool
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/18
Via Investor Brand Network
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
Via Benzinga
The 7 Most Promising Momentum Stocks to Own Now
These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility. 
Via InvestorPlace
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/12
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
From Cabaletta Bio
Via GlobeNewswire
Analyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
Guggenheim Securities initiated coverage of Cabaletta Bio Inc (NASDAQ: CABA) with a Buy rating and  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Via Benzinga
SPOT Stock Alert: Spotify Moves on Analyst Upgrade
Spotify (SPOT) stock is moving on Wednesday following an upgrade and price target from Wolfe Research analyst Zach Morrissey. 
Via InvestorPlace
Why Is Cabaletta Bio (CABA) Stock Down 8% Today?
Cabaletta Bio (CABA) stock is falling on Wednesday following news of insider selling at the targeted cell therapy company. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS